Altimmune Announces Notice of Allowance on Patent Covering Use of NasoShield in the U.S. Biotech Investing
ProMIS Neurosciences Lead Product Candidate for Alzheimer’s Disease Shows Potential for Improved Therapeutic Potency Biotech Investing
NanoSphere Health Sciences Inc. Signs License Agreement To Open California Market Cannabis Investing News
Acasti Pharma Announces the Closing of Over-Allotment Option for its Public Offering of Common Shares Biotech Investing
Histogenics Corporation Announces Pricing of Underwritten Registered Direct Offering of 2,340,430 Shares of Common Stock Biotech Investing
ChemoCentryx Announces Positive Overall Survival Results with CCR2 Inhibitor CCX872 Pharmaceutical Investing
